Serum fructosamine and risk of type 2 diabetes mellitus among middle-age Finnish men: a 23-year population-based prospective study

Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study

(2014) Elizabeth Selvin et al.   Lancet Diabetes & Endocrinology

Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality

(2013) Veronika Tanhäuserová et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis

(2013) D. H. Morris et al.   DIABETOLOGIA

The potential of novel biomarkers to improve risk prediction of type 2 diabetes

(2013) Christian Herder et al.   DIABETOLOGIA

Serum Fructosamine and Glycated Albumin and Risk of Mortality and Clinical Outcomes in Hemodialysis Patients

(2012) T. Shafi et al.   DIABETES CARE

Alternative Markers of Hyperglycemia and Risk of Diabetes

(2012) S. P. Juraschek et al.   DIABETES CARE

Nontraditional Markers of Glycemia: Associations with microvascular conditions

(2011) E. Selvin et al.   DIABETES CARE

Prediction models for incident Type 2 diabetes mellitus
in the older population: KORA S4/F4 cohort study

(2010) W. Rathmann et al.   DIABETIC MEDICINE

Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort

(2009) J. A. Kolberg et al.   DIABETES CARE

J-shaped relationship between waist circumference and subsequent risk for Type 2 diabetes: an 8-year follow-up of relatively lean Japanese individuals

(2009) M. Sakurai et al.   DIABETIC MEDICINE